oncoprotein - Robuta Search

https://www.ncbi.nlm.nih.gov/Structure/pdb/2FK4 2FK4: Solution structure of the C-terminal zinc binding domain of the HPV16 E6 oncoprotein https://pmc.ncbi.nlm.nih.gov/articles/PMC30974/ Interaction of the E1A Oncoprotein with Yak1p, a Novel Regulator of Yeast Pseudohyphal... The C-terminal portion of adenovirus E1A suppresses ras-induced metastasis and tumorigenicity in mammalian cells; however, little is known about the mechanisms... of the https://www.ncbi.nlm.nih.gov/Structure/pdb/1QTU 1QTU: SOLUTION STRUCTURE OF THE ONCOPROTEIN P13MTCP1 PROTEIN (PRODUCT OF THE MTCP1 ONCOGENE) of the solution structure oncoprotein https://www.ncbi.nlm.nih.gov/Structure/pdb/1IXV 1IXV: Crystal Structure Analysis of homolog of oncoprotein gankyrin, an interactor of Rb and CDK4/6 Probable 26S proteasome regulatory subunit p28 https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.658762/full Frontiers | Bovine Delta Papillomavirus E5 Oncoprotein Interacts With TRIM25 and Hampers Antiviral... Persistent infection and tumourigenesis by papillomaviruses (PVs) require viral manipulation of various of cellular processes, including those involved in in... https://www.news-medical.net/whitepaper/20190917/RAS-Oncoprotein-Drug-Discovery.aspx RAS Oncoprotein Drug Discovery Jun 18, 2020 - RAS oncoprotein drug discovery targets are key to finding cancerous cells and either immobilizing them for the immune system or destroying them. ras oncoprotein drug discovery https://www.agilent.com/en/product/immunohistochemistry/antibodies-controls/primary-antibodies/c-erbb-2-oncoprotein-%28concentrate%29-154013 c-erbB-2 Oncoprotein Antibody (Concentrate) | Agilent A synthetic peptide, coupled to keyhole limpet hemocyanin, has been used for immunization. The peptide represents part of the predicted 185 kDa oncoprotein... c erbb 2 oncoprotein antibody concentrate agilent https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.677867/full Frontiers | Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation... Despite prophylactic vaccination campaigns, high-risk human papillomavirus (HPV)-induced cervical cancer remains a significant health threat among women, esp... frontiers novel affibody molecules targeting https://pmc.ncbi.nlm.nih.gov/articles/PMC20928/ Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin... We have previously shown that the degradation of c-myc and N-myc in vitro is mediated by the ubiquitin system. However, the role of the system in targeting the... https://www.rcsb.org/structure/2H1L RCSB PDB - 2H1L: The Structure of the Oncoprotein SV40 Large T Antigen and p53 Tumor Suppressor... The Structure of the Oncoprotein SV40 Large T Antigen and p53 Tumor Suppressor Complex https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01784/full Frontiers | Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein... Rhabdomyosarcoma (RMS) is a highly malignant soft tissue sarcoma classified into two major histologic subtypes: embryonal (ERMS) and alveolar (ARMS). ARMS su... https://pmc.ncbi.nlm.nih.gov/articles/PMC19193/ Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein... Papillomavirus-like particles (VLPs) are a promising prophylactic vaccine candidate to prevent human papillomavirus (HPV) infections and associated epithelial...